A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives

Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
11/2001
11/29/2001	US20010046511 Water soluble film for oral administration with instant wettability
11/29/2001	US20010046507 Cosmetic and pharmaceutical oil in water emulsion comprising polyether modified polysiloxanes
11/29/2001	US20010046503 Reduction of adhesions using controlled delivery of active oxygen inhibitors
11/29/2001	US20010046487 Permeabilizing platelets by acid treatment; temperature and aging resistance
11/29/2001	US20010046481 Hydrolytically degradable carbamate derivatives of poly(ethylene glycol)
11/29/2001	US20010046478 Water soluble lacquers in combination with topical and systemic antimycotics
11/29/2001	US20010046476 Reactive group covalently bonded to a bactericide, flavorant and/or essential oil compound, hydrolyzable in aqueous solution for slow release
11/29/2001	US20010046474 Stabilized preparations for use in metered dose inhalers
11/29/2001	DE10025949A1 Arzneimittel zur Bekämpfung von Atemdepression Medications to fight respiratory depression
11/29/2001	DE10025948A1 Wirkstoffkombination Combination of active ingredients
11/29/2001	DE10025946A1 Wirkstoffkombination Combination of active ingredients
11/29/2001	DE10025558A1 Topische Zusammensetzung, enthaltend mindestens ein Aryloxim, und Verfahren zu ihrer Herstellung Topical composition comprising at least one aryl oxime, and processes for their preparation
11/29/2001	DE10024752A1 Composition for treating prostate diseases, especially inflammation, hyperplasia or cancer, comprises active agent solution containing dimethyl sulfoxide or hyaluronidase as diffusion promoter, applied using catheter
11/29/2001	DE10024451A1 Pharmazeutische Darreichungsform für Peptide, Verfahren zu deren Herstellung und Verwendung Pharmaceutical form of administration for peptides, process for their preparation and use
11/29/2001	DE10024384A1 Herstellung von dendritischen Zellen aus Rückenmarkstammzellen Preparation of dendritic cells from spinal cord stem cells
11/29/2001	DE10024383A1 Mit toxischen Substanzen beladene dendritische Zellen With toxic substances loaded dendritic cells
11/29/2001	DE10021894A1 Easily applied pharmaceutical composition for diagnosis and treatment of erectile dysfunction, comprises mixture of active agent, e.g. prostaglandin E1, and carrier forming gel in urethra
11/29/2001	CA2410567A1 Formulations and use of activated protein c and protein c zymogen for treating hypercoagulable states
11/29/2001	CA2410336A1 Transdermal therapeutical system with a reduced tendency of the active substance to crystallize
11/29/2001	CA2410293A1 Three-layer parenteral preparations
11/29/2001	CA2410219A1 Prolonged release microspheres for injection delivery and preparation method
11/29/2001	CA2410004A1 Aerosol container for formulations of salmeterol xinafoate
11/29/2001	CA2409980A1 Conjugates of aminodrugs comprising an oxime bond
11/29/2001	CA2409950A1 Pharmaceutical compositions comprising desglymidodrine as an active drug substance
11/29/2001	CA2409874A1 Porcine reproductive and respiratory syndrome virus (prrsv) recombinant avipoxvirus vaccine
11/29/2001	CA2409830A1 Sulfonamide derivatives
11/29/2001	CA2409688A1 Method for improving the cell protection
11/29/2001	CA2409592A1 Pharmceutical compositions comprising vip-related peptides for the treatment of sexual disorders
11/29/2001	CA2409051A1 Antimigraine combination comprising sapindus and emblica extracts
11/29/2001	CA2408781A1 Novel formulations of alpha-2,4-disulfophenyl-n-tert-butylnitrone
11/29/2001	CA2408562A1 Dehydroascorbic acid formulations and uses thereof
11/29/2001	CA2408033A1 Pharmaceutical composition comprising a free-radical scavenging sedative agent and a metal ion chelating agent
11/29/2001	CA2407764A1 O/w emulsion
11/29/2001	CA2407570A1 Compositions and methods for delivery of a molecule into a cell
11/29/2001	CA2405459A1 Solid dispersion system of pranlukast with improved dissolution, and the preparing method thereof
11/29/2001	CA2403574A1 Carbohydrate medical solution and sulphite stabilisator in a multiple compartment container and use thereof
11/28/2001	EP1158021A1 Microgels and external preparations containing the same
11/28/2001	EP1158014A1 Process for producing polymer
11/28/2001	EP1157703A2 Sustained release of peptides from pharmaceutical compositions
11/28/2001	EP1157689A1 Stable pharmaceutical solution formulations for pressurised metered dose inhalers
11/28/2001	EP1157688A1 Antibacterial aqueous ophthalmic formulations containing ofloxacin and chitosan
11/28/2001	EP1157275A1 Novel transduction molecules and methods for using same
11/28/2001	EP1157042A1 Production of tetravalent antibodies
11/28/2001	EP1157037A1 Gcsf conjugates
11/28/2001	EP1157030A1 Echinocandin/carbohydrate complexes
11/28/2001	EP1156831A1 Painless and tissue-conserving injection of medicaments
11/28/2001	EP1156830A2 Oil-in-water emulsion for the use as medicament or for producing a medicament
11/28/2001	EP1156825A2 Immunogens comprising a peptide and a carrier derived from h.influenzae protein d
11/28/2001	EP1156823A1 Methods for treatment of tumors and metastases using a combination of anti-angiogenic and immuno therapies
11/28/2001	EP1156820A1 Vascular endothelial growth factor-2
11/28/2001	EP1156818A2 Methods and compositions for regulating protein-protein interactions
11/28/2001	EP1156814A2 Novel pharmaceuticals, dietary supplements and cosmetic compositions, and the use of certain mixtures for preparing a medicament or a dietary supplement for the treatment or prevention of inflammation, hypersensitivity reactions or pain
11/28/2001	EP1156812A1 Multiparticulate formulation
11/28/2001	EP1156806A1 Pharmaceutical composition containing proton pump inhibitors
11/28/2001	EP1156797A2 Synergistic inhibition of viral replication by long-chain hydrocarbons and nucleoside analogs
11/28/2001	EP1156789A1 Therapy for human cancers using cisplatin and other drugs or genes encapsulated into liposomes
11/28/2001	EP1156788A1 Use of peg-derivatized lipids as surface stabilizers for nanoparticulate compositions
11/28/2001	EP1156787A1 Oxadiazole compounds and compositions for delivering active agents
11/28/2001	EP1156786A1 Orally dispersible tablet with low friability and method for preparing same
11/28/2001	EP1156770A1 Natural antioxidant compositions, method for obtaining same and cosmetic, pharmaceutical and nutritional formulations thereof
11/28/2001	EP0991407B1 Stabilization of acid sensitive benzimidazols with amino/cyclodextrin combinations
11/28/2001	EP0853483A4 Novel peptides
11/28/2001	EP0845993B1 Use of plasminogene activators to stimulate local bone growth
11/28/2001	EP0804225B1 Pharmaceutical compositions comprising a superoxide dismutase
11/28/2001	EP0783323B1 Transfer of molecules into the cytosol of cells by photosensitizing compounds
11/28/2001	EP0758244B1 Controlled-release dosage forms of azithromycin
11/28/2001	EP0727223B1 Polyamino acid oligonucleotide carrier
11/28/2001	CN1324380A Gel composition
11/28/2001	CN1324377A Urethane (meth) acrylates contg. siloxane groups and able to undergo free-radical polymerisation
11/28/2001	CN1324374A Biodegradable low molecular weight triblock polyester polyethylene glocol copolymers having reverse thermal gelation properties
11/28/2001	CN1324364A Phosphoglycolipid and methods for its use
11/28/2001	CN1324243A Method for treating inflammatory inflammatory diseases using heat shock proteins
11/28/2001	CN1324242A Novel NEUROPILIN/growth factor binding and use thereof
11/28/2001	CN1324241A Pharmaceutical compositions based on alpha-cyclodextrin for the oral administration of LH-RH analogues
11/28/2001	CN1324236A Delta 9 tetrahydrocannabinol (delta 9 THC) solution metered dose inhalers and methods of use
11/28/2001	CN1324235A Compositions of and process for producing isotretinoin having low particle size
11/28/2001	CN1324233A Controlled-release pharmaceutical formulations contg. a CGMP PDE-5 inhibitor
11/28/2001	CN1324232A Expandable gastroretentive therapeutic system with prolonged stomach retention time
11/28/2001	CN1323840A Aqueous high molecular film material for medicine coating
11/28/2001	CN1323633A Application of N-alkylbenzisothiazolidone as osmosis promoter
11/28/2001	CN1323579A Micro-capsule contg. water soluble beauty-care activity component water nuclear, and composition contg. same
11/28/2001	CN1075501C Camptothecin derivatives, prepn. method, intermediate and uses
11/27/2001	US6323326 Method of solubilizing, purifying, and refolding protein
11/27/2001	US6323322 Single-chain antigen-binding proteins capable of glycosylation, production and uses thereof
11/27/2001	US6323311 Synthesis of insulin derivatives
11/27/2001	US6323278 Method of making crosslinked polymer matrices in tissue treatment applications
11/27/2001	US6323241 Prostaglandin compositions and methods of treatment for male erectile dysfunction
11/27/2001	US6323191 Generation of chloride secretion from epithelial cells
11/27/2001	US6323189 Stable liquid composition consisting essentially of chitosan, non-fatty acid or salt thereof, and water or aqueous solution
11/27/2001	US6323175 Composition comprising physiologically compatible liposome, hemoglobin encapsulated in liposome, and nitroxide encapsulated in liposome
11/27/2001	US6322819 Amphetamine salt covered with enteric release coating
11/27/2001	US6322816 Fast-acting analgesic
11/27/2001	US6322815 Water soluble, high molecular weight polymer conjugated to drug, controlled release matrix of biocompatible second polymer
11/27/2001	US6322813 Compact member, method of manufacturing and use thereof
11/27/2001	US6322806 Over-coated chewing gum formulations including tableted center
11/27/2001	US6322805 Amphiphilic block polymer having units of polyethers and polylactones
11/27/2001	US6322804 Implantable biocompatible immunoisolatory vehicle for the delivery of selected therapeutic products
11/27/2001	US6322800 Incorporating into fatty phase a fluoroester like 2(f-octyl)ethyl as a stabilizing agent; used in cosmetic, hygiene or pharmaceutical composition
11/27/2001	US6322797 Biodegradable terephthalate polyester-poly (phosphate) polymers, compositions, articles, and methods for making and using the same
11/27/2001	US6322796 Immunological tolerance-inducing agent

1 ... 1281 1282 1283 1284 1285 1286 1287 1288 1289 1290 1291 1292 1293 1294 1295 1296 1297 1298 1299 1300 1301 ... 1712